难治性抑郁的临床问题200847.pptVIP

* * * * * * * * * * * * 19.8％ 12.3％ Figure 2. Time to Remissiona for Outpatients With Nonpsychotic Major Depressive Disorder Randomly Assigned to Mirtazapine or Nortriptyline After Two Consecutive Failed Medication Treatments aScore 5 on the 16-item Quick Inventory of Depressive-Symptomatology–Self Rated. 在所接受的治疗策略范围内进行随机分组 米氮平 去甲替林 锂盐 T3 转换治疗 联合(增效)治疗 获得知情同意书 治疗策略是否接受? 退出研究 STAR*D第三阶段治疗选择 否 是 15.9% 24.7% 因不良反应脱落的更多 减分少 Nierenberg Figure 2. Cumulative Probability of Remissiona for Outpatients With Major Depressive Disorder Receiving Lithium or T3 Augmentation Treatment in STAR*D Level 3, by